ストックスクリーナーアプリを入手
4.37
6.33%
0.26
アフターアワーズ：
4.37
前日終値:
$4.11
開ける：
$4.13
24時間の取引高:
433.71K
Relative Volume:
1.96
時価総額：
$134.49M
収益：
$71.61M
当期純損益:
$-48.59M
株価収益率:
-2.4957
EPS:
-1.751
ネットキャッシュフロー:
$-32.88M
1週間 パフォーマンス:
+2.10%
1か月 パフォーマンス:
-12.77%
6か月 パフォーマンス:
+10.35%
1年 パフォーマンス:
-37.30%
1日の値動き範囲:
$4.11
$4.47
1週間の範囲:
$4.01
$4.48
52週間の値動き範囲:
$3.22
$7.4299
Avita Medical Inc Stock (RCEL) Company Profile
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.37 | 126.49M | 71.61M | -48.59M | -32.88M | -1.751 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-05 | 開始されました | Northland Capital | Outperform |
| 2025-11-20 | アップグレード | BTIG Research | Sell → Neutral |
| 2025-08-08 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
AVITA Medical Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Avita Medical (RCEL) Expected to Announce Earnings on Thursday - MarketBeat
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
AVITA Medical appoints Cary Vance as permanent CEO - MSN
Avita Medical Names Cary Vance Permanent CEO, Reshapes Board - The Globe and Mail
AVITA Medical Appoints Cary Vance as Permanent CEO and Jan Stern Reed as Board Chair to Drive Growth in Acute Wound Care Solutions - Minichart
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen - MarketBeat
AVITA Medical wins BARDA contract worth up to $25.5M - MSN
Cary Vance becomes AVITA Medical (NASDAQ: RCEL) CEO as Board elevates Jan Stern Reed to Chair - Stock Titan
Avita Medical Appoints CEO, Chair - Moomoo
AVITA Medical Names Cary Vance as Chief Executive Officer - Investing News Network
AVITA Medical names Cary Vance as permanent CEO - Investing.com
AVITA Medical names Cary Vance as permanent CEO By Investing.com - Investing.com Australia
After 6 months as interim CEO, Cary Vance gets AVITA's top job - Stock Titan
Avita Medical (RCEL) Secures Certification for Recell Go in Aust - GuruFocus
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO - Investing News Network
AVITA Medical gains regulatory clearance for RECELL GO in Australia By Investing.com - Investing.com Canada
Burn care tool cleared for sale in Australia and New Zealand - Stock Titan
Why this ASX healthcare stock is surging while the market sinks on Middle East fears - MSN
AVITA Medical appoints Cary Vance as interim CEO - MSN
Avita Medical (RCEL) upgraded to buy: Here's what you should know - MSN
Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity - MSN
AVITA Medical to Announce First Quarter 2026 Financial Results - The Manila Times
AVITA Medical schedules May 14 earnings release, 1:30 p.m. call - Stock Titan
Guess which ASX All Ords healthcare share is jumping 11% on big European news - MSN
Is Avita Medical (RCEL) stock under bearish pressure | Q4 2025: Below ExpectationsCyclicality - Cổng thông tin điện tử tỉnh Tây Ninh
Board pay, director equity and warrants on AVITA Medical (NASDAQ: RCEL) 2026 ballot - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc.RCEL - ChartMill
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
3.34%
大文字化:
|
ボリューム (24 時間):